Join
Live feed
·
PRReleasevia Quantisnow
BioNexus Gene Lab Corp logo

BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard™ MRD Platform

ByQuantisnow·Wall Street's wire, on your screen.
BGLC· BioNexus Gene Lab Corp
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BGLC (BioNexus Gene Lab Corp) and more on Quantisnow.

BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard™ MRD Platform | Quantisnow